Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07176936 · ClinicalTrials.gov registry record · NA
Improving Speech in Noise Using Noninvasive Stimulation
A NA study, sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT07176936: Recruiting NA study, sponsored by University of Florida.
NCT07176936 is a NA study that is actively recruiting participants, run by University of Florida. The registered enrollment target is 55 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07176936, a NA study, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
Traumatic brain injury, a common injury in military service personnel, often leads to poor processing of speech in noisy environments. The goal of the current study is to better understand the brain basis for this difficulty and evaluate a new approach to improving speech in noise perception.
Primary Outcome
quantify attrition as well as frequency and severity of adverse events
Interventions
- DEVICE Cymba Conchae stimulation
- DEVICE Earlobe stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2026-03-21 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
What NCT07176936 shows while recruiting
NCT07176936 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Cymba Conchae stimulation is the first listed.
NCT07176936 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07176936 about?
NCT07176936 is a clinical study titled "Improving Speech in Noise Using Noninvasive Stimulation". Traumatic brain injury, a common injury in military service personnel, often leads to poor processing of speech in noisy environments. The goal of the current study is to better understand the brain basis for this difficulty and evaluate a new approach to improving speech in noise perception.
What is the current status of trial NCT07176936?
This trial is currently recruiting. It is a NA study. The enrollment target is 55 participants. The study started on 2026-03-21. Estimated completion is 2027-08-31.
What interventions are being tested in trial NCT07176936?
The interventions under investigation include: Cymba Conchae stimulation (DEVICE), Earlobe stimulation (DEVICE).
Who is sponsoring clinical trial NCT07176936?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07176936's enrollment target sits among peer trials
55 1264th of 2000 higher than 733 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI